Riskpilot← Back to searchSign inGet full accessCBRA AS
ASActiveOrg 989388126Billingstadåsen 40, 1396 BillingstadMedical specialists activities · NACE 8622Est. 20066 employees
Revenue 2024
NOK 12,6M
-18% vs 2023
EBITDA margin
41.2%
+58% vs 2023
Equity ratio
92.0%
Financial strength
Net profit 2024
NOK 4,6M
+1237% vs 2023
| Revenue | NOK 12,6M | -18% |
| EBITDA | NOK 5,2M | +58% |
| Net profit | NOK 4,6M | +1237% |
| Total assets | NOK 31,6M | +3% |
| Equity | NOK 29,1M | +13% |
| Employees | 6 | — |
Legal name
CBRA AS
Org number
989388126
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
6. februar 2006
Share capital
NOK 100 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av helsetjenester samt deltakelse i andre selskap og alt som hører dertil.
Address
Billingstadåsen 40, 1396 Billingstad
Phone
+4763803980
Email
post@bymedhus.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 382 | 14 723 | 15 558 | 15 315 | 12 610 |
| Staff expenses | −3 984 | −4 414 | −4 538 | −4 846 | −2 364 |
| EBITDA | 5 493 | 4 464 | 4 422 | 3 298 | 5 195 |
| Depreciation & amort. | −243 | −299 | −289 | −271 | −184 |
| EBIT | 5 250 | 4 165 | 4 133 | 3 027 | 5 012 |
| Net financials | 1 901 | 697 | 74 | −2 692 | 856 |
| Profit before tax | 7 150 | 4 862 | 4 207 | 335 | 5 868 |
| Tax | 1 176 | 925 | 935 | 741 | 1 251 |
| Net profit | 5 974 | 3 937 | 3 272 | −406 | 4 616 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30 313 | 33 032 | 33 169 | 30 749 | 31 576 |
| Equity | 27 334 | 29 207 | 29 117 | 25 711 | 29 061 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 978 | 3 826 | 4 052 | 5 038 | 2 515 |
| Total debt | 2 978 | 3 826 | 4 052 | 5 038 | 2 515 |
EBITDA margin
41.2%
This company
15.8%
Market median
+161% vs market
20202024
Equity ratio
92.0%
This company
38.2%
Market median
+141% vs market
20202024
Return on equity
15.9%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
36.6%
This company
8.1%
Market median
+352% vs market
20202024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JT Deputy Member | Deputy Member | 2006 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2006 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CBRA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Terje Ludvigsen | Deputy Member | 0 companies |
| John Kolbjørn Birkelund | Chairman | 0 companies |